Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

ClinicalTrials.gov ID: NCT05463744

Public ClinicalTrials.gov record NCT05463744. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Study identification

NCT ID
NCT05463744
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
692 participants

Conditions and interventions

Interventions

  • Insulin Degludec Drug
  • Insulin Efsitora Alfa Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2022
Primary completion
May 6, 2024
Completion
May 6, 2024
Last update posted
Jun 23, 2025

2022 – 2024

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
30
Facility City State ZIP Site status
John Muir Physician Network Research Center Concord California 94520
Valley Research Fresno California 93720
Catalina Research Institute, LLC Montclair California 91763
Sansum Diabetes Research Institute Santa Barbara California 93105
University Clinical Investigators, Inc. Tustin California 92780
University of Colorado Anschutz Medical Campus Aurora Colorado 80045
Northeast Research Institute (NERI) Fleming Island Florida 32003
Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care Fort Lauderdale Florida 33312
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Hanson Clinical Research Center Port Charlotte Florida 33952
East Coast Institute for Research at The Jones Center Macon Georgia 31210
East-West Medical Research Institute Honolulu Hawaii 96814
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
Cotton O'Neil Clinical Research Center Topeka Kansas 66606
MedStar Health Research Institute (MedStar Physician Based Research Network) Hyattsville Maryland 20782
Endocrine and Metabolic Consultants Rockville Maryland 20852
Clinvest Research LLC Springfield Missouri 65807
Palm Research Center Tenaya Las Vegas Nevada 89128
Palm Research Center Sunset Las Vegas Nevada 89148
Research Foundation of SUNY - University of Buffalo Buffalo New York 14221
NYU Langone Hospital - Long Island Mineola New York 11501
NYC Research New York New York 10016
SUNY Upstate Medical University Syracuse New York 13210
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731
Dallas Diabetes Research Center Dallas Texas 75230
North Texas Endocrine Center Dallas Texas 75231
Research Institute of Dallas Dallas Texas 75231
Biopharma Informatic, LLC Houston Texas 77043
Amir A Hassan, MD, PA Houston Texas 77089
Southern Endocrinology Associates Mesquite Texas 75149
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05463744, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05463744 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →